Insider Transactions in Q1 2024 at Hanover Bancorp, Inc. (HNVR)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 05
2024
|
Philip A Okun Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,938
-11.6%
|
$79,008
$16.48 P/Share
|
|
Mar 05
2024
|
Philip A Okun Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,139
+16.05%
|
$81,390
$10.0 P/Share
|
|
Mar 01
2024
|
Metin Negrin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+0.89%
|
-
|
|
Mar 01
2024
|
Philip A Okun Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+5.79%
|
-
|
|
Mar 01
2024
|
Varkey Abraham Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+5.08%
|
-
|
|
Mar 01
2024
|
Robert Golden Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+6.42%
|
-
|
|
Mar 01
2024
|
Elena Sisti Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+2.08%
|
-
|
|
Mar 01
2024
|
Michael David M.D. Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+1.42%
|
-
|
|
Mar 01
2024
|
Ahron H Haspel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+8.56%
|
-
|
|
Mar 01
2024
|
John R Sorrenti Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,117
+4.56%
|
-
|
|
Feb 20
2024
|
Lance P Burke EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,040
-2.38%
|
$17,680
$17.6 P/Share
|
|
Feb 20
2024
|
Mc Clelland W Wilcox President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,974
-1.78%
|
$50,558
$17.6 P/Share
|
|
Feb 20
2024
|
Lisa A Diiorio FSVP & Chief Accounting Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
428
-2.79%
|
$7,276
$17.6 P/Share
|
|
Jan 31
2024
|
Robert Golden Director |
BUY
Open market or private purchase
|
Direct |
500
+1.71%
|
$9,000
$18.0 P/Share
|
|
Jan 29
2024
|
Elena Sisti Director |
BUY
Open market or private purchase
|
Direct |
2,750
+2.74%
|
$49,500
$18.01 P/Share
|
|
Jan 29
2024
|
Michael David M.D. Katz Director |
BUY
Open market or private purchase
|
Direct |
700
+0.48%
|
$12,600
$18.02 P/Share
|
|
Jan 19
2024
|
Lisa A Diiorio FSVP & Chief Accounting Off. |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+6.13%
|
-
|
|
Jan 19
2024
|
Lance P Burke EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+11.32%
|
-
|
|
Jan 19
2024
|
Mc Clelland W Wilcox President |
BUY
Grant, award, or other acquisition
|
Direct |
7,745
+8.44%
|
-
|
|
Jan 19
2024
|
Kevin Corbett EVP & Chief Credit Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+10.63%
|
-
|
|
Jan 19
2024
|
Michael P Puorro Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,300
+3.92%
|
-
|